These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25392352)

  • 21. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
    Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
    Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Six Antifungal Susceptibilities of 11
    Lee H; Choi SH; Oh J; Koo J; Lee HJ; Cho SI; Shin JH; Lee HK; Kim SY; Lee CH; Kim YR; Sohn YH; Kim WJ; Ryu SW; Sung GH; Kim J
    Microbiol Spectr; 2022 Apr; 10(2):e0125321. PubMed ID: 35384691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EUCAST Reference Testing of Rezafungin Susceptibility and Impact of Choice of Plastic Plates.
    Arendrup MC; Jørgensen KM; Hare RK; Cuenca-Estrella M; Zaragoza O
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff values.
    Pfaller MA; Espinel-Ingroff A; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2011 Mar; 49(3):845-50. PubMed ID: 21227994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APX001A
    Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.
    Diekema DJ; Messer SA; Boyken LB; Hollis RJ; Kroeger J; Tendolkar S; Pfaller MA
    J Clin Microbiol; 2009 Oct; 47(10):3170-7. PubMed ID: 19710283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
    Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):37-40. PubMed ID: 23870164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2005 Nov; 43(11):5425-7. PubMed ID: 16272464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp.
    Sims CR; Paetznick VL; Rodriguez JR; Chen E; Ostrosky-Zeichner L
    J Clin Microbiol; 2006 Jun; 44(6):2105-8. PubMed ID: 16757605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria.
    Beyer R; Spettel K; Zeller I; Lass-Flörl C; Achleitner D; Krause R; Apfalter P; Buzina W; Strauss J; Gregori C; Schüller C; Willinger B
    Mycoses; 2019 Apr; 62(4):357-367. PubMed ID: 30636016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp.
    Cretella D; Barber KE; King ST; Stover KR
    J Med Microbiol; 2016 Dec; 65(12):1445-1451. PubMed ID: 27902377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.
    Martín-Mazuelos E; Gutiérrez MJ; Aller AI; Bernal S; Martínez MA; Montero O; Quindós G
    J Antimicrob Chemother; 1999 Apr; 43(4):477-81. PubMed ID: 10350375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
    García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
    Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
    Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2007 Jan; 45(1):70-5. PubMed ID: 17079501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole.
    Diekema DJ; Messer SA; Hollis RJ; Boyken LB; Tendolkar S; Kroeger J; Pfaller MA
    J Clin Microbiol; 2007 Jun; 45(6):1974-7. PubMed ID: 17301284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods.
    Sóczó G; Kardos G; McNicholas PM; Falusi E; Gergely L; Majoros L
    Mycoses; 2007 May; 50(3):178-82. PubMed ID: 17472612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of anidulafungin MICs determined by the clinical and laboratory standards institute broth microdilution method (M27-A3 document) and Etest for Candida species isolates.
    Espinel-Ingroff A; Canton E; Peman J; Martín-Mazuelo E
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1347-50. PubMed ID: 20028814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species.
    Chryssanthou E; Cuenca-Estrella M
    J Clin Microbiol; 2002 Oct; 40(10):3841-4. PubMed ID: 12354895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria.
    Aigner M; Erbeznik T; Gschwentner M; Lass-Flörl C
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.